北京同仁堂集团致歉！

Core Viewpoint - Beijing Tongrentang Group issued an apology regarding the Antarctic krill oil incident, emphasizing a zero-tolerance policy towards brand management and consumer protection [1][2]. Group 1: Company Actions - The company has initiated a special task force to conduct a thorough investigation of the involved products in Sichuan, ensuring a comprehensive inquiry [2]. - The company has ordered the immediate removal of the implicated products from the market and is supervising compliance with regulatory requirements for consumer compensation [2]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [2][3]. Group 2: Brand Protection Measures - The company is conducting a comprehensive review of brand usage to identify any illegal or non-compliant practices across its subsidiaries [2]. - A brand cleanup initiative is underway to eliminate improper use of the "Tongrentang" name and ensure strict adherence to brand management standards [2]. - The company is standardizing e-commerce platform store identifiers to ensure the correct use of the "Tongrentang" double-dragon logo, guiding consumers to recognize legitimate purchasing channels [3]. Group 3: Incident Background - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to falsely claim high phospholipid content, with testing revealing a phospholipid content of 0% [3]. - The implicated product was produced by Anhui Habao Pharmaceutical Co., Ltd., and distributed by Sichuan Tongrentang Health Pharmaceutical Co., Ltd., which is a subsidiary of Beijing Tongrentang Group [3][7]. - The company clarified that Sichuan Tongrentang Health Pharmaceutical is not a direct subsidiary of Beijing Tongrentang but is under the control of its parent company [7].